Defiance Act Drops to 16% as House Judiciary Ignores Unanimous Senate Vote

---

The Defiance Act Passed the Senate 100-0. So Why Are Prediction Markets Pricing It as Dead?

The Defiance Act cleared the Senate on January 13, 2026, without a single dissenting vote. A 100-0 result on legislation targeting non-consensual sexually explicit deepfake images should, by every conventional reading of legislative momentum, have been a fast track to the president's desk. Senator Dick Durbin and Senator Lindsey Graham co-sponsored the bill. Representatives Alexandria Ocasio-Cortez and Laurel Lee carry the House companion, H.R. 3562. Bipartisan support at every level. Zero opposition on record.

None of that has mattered. The Defiance Act now trades at 16% implied probability on the question of which bills will become law in 2026, down 27 percentage points from 43% just three days ago. The resolution deadline is December 31, 2026. Five months remain, and the bill has not advanced a single procedural step in the House.

Prediction-market view

Live prices, venue by venue

Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.

DEFIANCE Act

Consensus YES price across 2 venues

3%average

PolymarketBest YES price3.6¢Kalshi4.5¢

College sports federalization

Consensus YES price across 1 venues

47%average

KalshiBest YES price47¢

ADS-B revenue-use restriction

Consensus YES price across 1 venues

28%average

KalshiBest YES price29¢

Insulin cost cap

Consensus YES price across 1 venues

36%average

KalshiBest YES price60¢

Current new-user offer · Kalshi

Get a $35 trading bonusCode PRED35

New users only. Eligibility restrictions and terms apply.

View current offer

The collapse isn't irrational panic. It reflects a specific, identifiable chokepoint that has held for six straight months. The next section names it.

---

House Judiciary Committee Is Where Bills Go to Disappear

Here is the core fact that makes the 16% price rational: as of July 14, 2026, the House Judiciary Committee has not scheduled a single hearing or markup for H.R. 3562. Not one. The bill has sat untouched since its referral.

Committee chairs in the House exercise near-absolute control over which bills receive floor time. The Judiciary Committee chair can decline to schedule a hearing indefinitely, and no mechanism short of a discharge petition (requiring 218 signatures, a procedural unicorn) can force the issue. In practice, the chair's scheduling decision functions as a silent veto. The majority of bills that pass one chamber die exactly this way: not through a vote, but through the absence of one.

This pattern is not unusual in the abstract. Congressional Research Service data consistently shows that fewer than 10% of bills referred to committee ever receive a markup. What makes the Defiance Act case notable is the strength of the signal the Senate sent. Unanimous consent votes are extraordinarily rare for substantive legislation. The market initially priced that signal correctly, pushing odds above 50% earlier this year. The repricing since then reflects the market learning, week by week, that the Senate signal carried no weight in the House.

But markets didn't always see this as a kill shot. The move from 43% to 16% happened fast. What changed?

---

What Broke the Defiance Act's Momentum: Inside the 27-Point Odds Collapse

The honest answer: no single public catalyst cleanly explains the full 27-percentage-point drop over three days. No House Judiciary leadership statement about scheduling priorities surfaced in the last 72 hours. No competing bill displaced H.R. 3562 on the committee calendar. The move appears to be an acceleration of a trend already in motion. The Defiance Act was at 28% on July 14. It had been sliding for weeks before this final leg down.

What likely contributed to the broader repricing environment is a growing market consensus that legislative action on several fronts has stalled. On July 19, TD Cowen analysts stated that three bills targeting prediction markets are unlikely to pass in the current session, reinforcing a narrative of congressional inertia. Arizona Governor Katie Hobbs's July 20 executive order banning executive branch employees from wagering on prediction markets with nonpublic information added to the sense that regulatory action is happening at the state level precisely because Congress won't act.

The calendar itself may be the strongest catalyst. With Congress approaching its August recess and only five months until the December 31 resolution date, every week without a hearing reduces the remaining legislative runway. At some point, the accumulation of inaction crosses a threshold where traders stop discounting the possibility of late-session action and start treating the bill as dead. The 27-percentage-point drop suggests that threshold was crossed in the last few days. Kalshi prices the Defiance Act at 22%, while Polymarket sits lower at 9%, indicating that even among prediction market platforms, there is disagreement about how dead this bill really is.

---

The Bull Case for the Defiance Act: What Would Need to Be True for Markets to Be Wrong

At 16%, the market is saying there is roughly a one-in-six chance the Defiance Act becomes law by year-end. That is not zero. Here is what the remaining probability is pricing in.

First, the issue has genuine bipartisan urgency. Deepfake sexual exploitation has accelerated throughout 2026, generating recurring media cycles that create pressure on House members in competitive districts. A high-profile incident involving a public figure or a minor could generate the kind of constituent outrage that forces a committee chair's hand.

Second, the procedural path is short once activated. The Senate has already passed its version. If the House Judiciary Committee were to schedule and pass a markup, the bill could move to the House floor on an expedited basis. A clean companion bill matching the Senate text would not require a conference committee, meaning enactment could happen in weeks, not months.

Third, lame-duck sessions historically produce legislative bursts. If the November elections shift the political calculus, the post-election session in November and December could provide a window. Members leaving office or seeking bipartisan accomplishments sometimes clear backlogs.

The bear case is simpler and stronger: the House Judiciary chair has had six months to act and has chosen not to. Nothing in the public record suggests that calculation is about to change. The recess further compresses the timeline. And the broader legislative environment, as TD Cowen noted, favors inaction.

My read: 16% is defensible but may be slightly generous given the complete absence of committee engagement. The Kalshi-Polymarket spread (22% vs. 9%) suggests the market hasn't fully converged on a consensus. If no hearing is scheduled before September, expect the remaining probability to compress toward single digits. The Defiance Act's unanimous Senate vote is now a historical footnote, not a legislative asset.